Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
6
7
9
10
11
12
13
14
18
19
20
21
23
27
28
30
12:00 AM - Hepatology 2021
31
1
2
3
4
Heart Care and Diseases 2021
2021-03-03    
All Day
Euro Heart Conference 2020 will join world-class professors, scientists, researchers, students, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, [...]
Gastroenterology and Digestive Disorders
2021-03-04 - 2021-03-05    
All Day
Gastroenterology Diseases is clearing a worldwide stage by drawing in 2500+ Gastroenterologists, Hepatologists, Surgeons going from Researchers, Academicians and Business experts, who are working in [...]
Environmental Toxicology and Ecological Risk Assessment
2021-03-04 - 2021-03-05    
All Day
Environmental Toxicology 2021 you can meet the world leading toxicologists, biochemists, pharmacologists, and also the industry giants who will provide you with the modern inventions [...]
Dermatology, Cosmetology and Plastic Surgery
2021-03-05 - 2021-03-06    
All Day
Market Analysis Speaking Opportunities Speaking Opportunities: We are constantly intrigued by hearing from professionals/practitioners who want to share their direct encounters and contextual investigations with [...]
World Dental Science and Oral Health Congress
2021-03-08 - 2021-03-09    
All Day
About The Webinar Conference Series LLC Ltd invites you to attend the 42nd World Dental Science and Oral Health Congress to be held in March 08-09, 2021 with the [...]
Euro Metabolomics & Systems Biology
2021-03-08 - 2021-03-09    
All Day
Euro Metabolomics 2021 will be a platform to investigate recent research and advancements that can be useful to the researchers. Metabolomics is a rapidly emerging [...]
International Summit on Industrial Engineering
2021-03-15 - 2021-03-16    
All Day
Industrial Engineering conference invites all the participants to attend International summit on Industrial Engineering during March15-16, 2021 Webinar. This has prompt keynotes, Oral talks, Poster [...]
Digital Health 2021
2021-03-15 - 2021-03-16    
All Day
The use of modern technologies and digital services is not only changing the way we communicate, they also offer us innovative ways for monitoring our [...]
Genetics and Molecular biology 2021
2021-03-15    
All Day
Human genetics is study of the inheritance of characteristics by children from parents. Inheritance in humans does not differ in any fundamental way from that [...]
Food Science and Food Safety
2021-03-16 - 2021-03-17    
All Day
Food Safety. It also provides the premier multidisciplinary forum for researchers, professors and educators to present and discuss the most recent innovations, trends, and concerns, [...]
Traditional and Alternative Medicine
2021-03-16 - 2021-03-17    
All Day
Traditional Medicine 2021 welcomes attendees, presenters, and exhibitors from all over the world. We are glad to invite you all to attend and register for [...]
Carbon and Advanced Energy Materials
2021-03-16 - 2021-03-17    
All Day
Materials Science 2021 was an enchanted achievement. We give incredible credits to the Organizing Committee and participants of Materials Science 2021 Conference. Numerous tributes from [...]
Advancements in Tuberculosis and Lung Diseases
2021-03-17 - 2021-03-18    
All Day
Tuberculosis is a communicable disease, caused by the infectious bacterium Mycobacterium tuberculosis. It affects the lungs and other parts of the body (brain, spine). People [...]
Herbal Medicine and Acupuncture 2021
2021-03-22 - 2021-03-23    
All Day
The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and [...]
Hospital Management and Health Care
2021-03-22 - 2021-03-23    
All Day
Healthcare system refers to the totality of resource that a society distributes with in organization and health facilities delivery for the aim of upholding or [...]
Hematology and Infectious Diseases
2021-03-22 - 2021-03-23    
All Day
Hematology is the discipline concerned with the production, functions, bone marrow, and diseases which are related to blood, blood proteins. The main aim of this [...]
Aquaculture & Marine Biology
2021-03-24 - 2021-03-25    
All Day
The 15th International Conference on Aquaculture & Marine Biology is delighted to welcome the participants from everywhere the planet to attend the distinguished conference scheduled [...]
Artificial Intelligence & Robotics 2021
2021-03-24 - 2021-03-25    
All Day
The Conference Series LLC Ltd organizes conferences around the world on all computer science subjects including Robotics and its related fields. Here we are happy [...]
Tissue Engineering & Regenerative Medicine
2021-03-24 - 2021-03-25    
All Day
Tissue Engineering & Regenerative Medicine mainly focuses on Stem Cell Research and Tissue Engineering. Stem cell Research includes stem cell treatment for various disease and [...]
Nursing Research and Evidence Based Practice
2021-03-25 - 2021-03-26    
12:00 am
Global Nursing Practice 2021 has been circumspectly organized with various multi and interdisciplinary tracks to accomplish the middle objective of the gathering that is to [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Nanomaterials and Nanotechnology
2021-03-26 - 2021-03-27    
All Day
Nanomaterials are the elements which have at least one spatial measurement in the size range of 1 to 100 nanometre. Nanomaterials can be produced with [...]
Smart Materials and Nanotechnology
2021-03-29 - 2021-03-30    
All Day
Smart Material 2021 clears a stage to globalize the examination by introducing an exchange amongst ventures and scholarly associations and information exchange from research to [...]
World Nanotechnology Congress 2021
2021-03-29    
All Day
Nano Technology Congress 2021 provides you with a unique opportunity to meet up with peers from both academic circle and industries level belonging to Recent [...]
Nanomedicine and Nanomaterials 2021
2021-03-29    
All Day
NanoMed 2021 conference provides the best platform of networking and connectivity with scientist, YRF (Young Research Forum) & delegates who are active in the field [...]
Hepatology 2021
2021-03-30 - 2021-03-31    
All Day
Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range [...]
Events on 2021-03-03
Events on 2021-03-05
Events on 2021-03-17
Events on 2021-03-25
Events on 2021-03-30
Hepatology 2021
30 Mar 21
Latest News

Lisanti Capital Growth LLC Increases Position in Vocera Communications Inc (VCRA)

HIMSS21

Lisanti Capital Growth LLC increased its position in Vocera Communications Inc (NYSE:VCRA) by 20.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 115,120 shares of the communications equipment provider’s stock after acquiring an additional 19,625 shares during the quarter. Vocera Communications comprises 1.8% of Lisanti Capital Growth LLC’s investment portfolio, making the stock its 14th largest holding. Lisanti Capital Growth LLC owned approximately 0.38% of Vocera Communications worth $4,530,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc lifted its position in Vocera Communications by 1.6% in the 3rd quarter. Vanguard Group Inc now owns 1,382,125 shares of the communications equipment provider’s stock worth $50,558,000 after buying an additional 21,962 shares during the last quarter. Dimensional Fund Advisors LP bought a new stake in Vocera Communications in the 3rd quarter worth approximately $1,065,000. Janus Henderson Group PLC bought a new stake in Vocera Communications in the 3rd quarter worth approximately $23,805,000. Prudential Financial Inc. bought a new stake in Vocera Communications in the 3rd quarter worth approximately $1,715,000. Finally, Bank of New York Mellon Corp increased its stake in Vocera Communications by 17.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 196,821 shares of the communications equipment provider’s stock worth $7,200,000 after purchasing an additional 29,688 shares during the period.

Get Vocera Communications alerts:

A number of brokerages have commented on VCRA. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $45.00 price target on shares of Vocera Communications in a research note on Friday, January 11th. Robert W. Baird reissued a “buy” rating and set a $40.00 target price on shares of Vocera Communications in a research note on Friday, November 30th. Citigroup cut Vocera Communications from a “buy” rating to a “neutral” rating in a research note on Friday, February 8th. Zacks Investment Research raised Vocera Communications from a “hold” rating to a “buy” rating and set a $44.00 target price on the stock in a research note on Tuesday, January 1st. Finally, Dougherty & Co cut Vocera Communications from a “buy” rating to a “neutral” rating in a research note on Monday, January 14th. They noted that the move was a valuation call. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $38.40.

NYSE VCRA opened at $32.33 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.46 and a current ratio of 4.52. Vocera Communications Inc has a twelve month low of $22.43 and a twelve month high of $42.60. The company has a market cap of $966.82 million, a P/E ratio of -190.18 and a beta of 0.31.

Vocera Communications (NYSE:VCRA) last released its quarterly earnings results on Thursday, February 7th. The communications equipment provider reported $0.18 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. Vocera Communications had a negative return on equity of 3.37% and a negative net margin of 5.39%. The company had revenue of $48.88 million for the quarter, compared to analyst estimates of $49.82 million. During the same period in the previous year, the company posted $0.22 earnings per share. The firm’s revenue was up 10.8% on a year-over-year basis. Research analysts predict that Vocera Communications Inc will post -0.29 EPS for the current fiscal year.

In other news, General Counsel Douglas Alan Carlen sold 1,990 shares of the company’s stock in a transaction on Friday, February 15th. The stock was sold at an average price of $30.31, for a total transaction of $60,316.90. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Mary Bridget Duffy sold 31,545 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $32.21, for a total value of $1,016,064.45. Following the transaction, the insider now directly owns 90,873 shares in the company, valued at $2,927,019.33. The disclosure for this sale can be found here. Insiders sold 105,788 shares of company stock worth $3,873,164 over the last three months. Corporate insiders own 4.90% of the company’s stock.

About Vocera Communications

Vocera Communications, Inc provides secure, integrated, and intelligent communication and workflow solutions that empowers mobile workers in healthcare, hospitality, energy, and other mission-critical mobile work environments in the United States and internationally. The company’s communication solution could be integrated with other clinical systems, including electronic health records, nurse call systems, and patient monitoring, as well as to provide critical data, alerts, alarms, and clinical context that enable workflow.

 

Source